Screener
Corcept Therapeutics CORT Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: Corcept Therapeutics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050613
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Income (loss) from operations | 41,300 | 26,675 | (8,301) | 30,091 |
| Interest and other income | 4,631 | 5,017 | 9,517 | 11,219 |
| Income before income taxes | 45,931 | 31,692 | 1,216 | 41,310 |
| Income tax (expense) benefit | (2,944) | 3,457 | 10,010 | 14,386 |
| Net income | 42,987 | 35,149 | 11,226 | 55,696 |
| Net income attributable to common stockholders | 42,141 | 34,611 | 11,017 | 54,918 |
| Basic net income per common share | $0.40 | $0.33 | $0.11 | $0.53 |
| Diluted net income per common share | $0.36 | $0.29 | $0.09 | $0.46 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Corcept Therapeutics's income tax?
- Corcept Therapeutics (CORT) reported income tax of $2.94M in Q2 2026.
- How has Corcept Therapeutics's income tax changed year-over-year?
- Corcept Therapeutics's income tax increased by 185.2% year-over-year, from -$3.46M to $2.94M.
- What is the long-term trend for Corcept Therapeutics's income tax?
- Over 4 years (2021 to 2025), Corcept Therapeutics's income tax has grown at a 27.7% compound annual growth rate (CAGR), from $12.49M to -$33.19M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.
Ask your AI about Corcept Therapeutics's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude